首页 > 最新文献

KIDNEYS最新文献

英文 中文
Nephrological care in the conditions of martial law in Ukraine 乌克兰戒严令条件下的肾病护理
Pub Date : 2022-09-24 DOI: 10.22141/2307-1257.11.3.2022.372
L.D. Denova, D. Ivanov, R.R. Andrunevich, O. Korzh, E. Krasyuk
During armed conflicts (AC) and other disasters, the elderly, women, children, the infirm and the chronically ill patients are the most vulnerable population, with a high risk to health and life. Chronically ill people with kidney diseases, including those with kidney failure, deserve special attention due to their complete dependence on available functional infrastructure, and access to vital drugs and well-trained personnel. Currently, there is little information on the effects of AC on patients with kidney damage compared to the available data about the effects of other disasters. Mechanisms of injuries in AC and natural or man-made disasters have similar and distinctive features. Distinctive features: during AC — mainly gunshot and mine blast injuries, bleedings, poisonings by toxic substances, during disasters — hypothermia or burns, mechanical injuries, etc. Similar features include damage to infrastructure, particularly health care facilities, shortage of medicines, medical personnel, humanitarian and other crises, and a large number of injured and traumatized people in the hospitals. In this article, we systematized the material obtained during the military conflict, as well as reviewed domestic and foreign articles on this topic in order to optimize the work of nephrologists in the conditions of martial law and limited resources.
在武装冲突和其他灾害期间,老年人、妇女、儿童、体弱者和慢性病患者是最脆弱的人群,他们的健康和生命面临着很高的风险。慢性肾病患者,包括肾衰竭患者,值得特别关注,因为他们完全依赖现有的功能性基础设施,并可获得重要药物和训练有素的人员。目前,与有关其他灾害影响的现有数据相比,关于交流电对肾损害患者的影响的信息很少。自然灾害和人为灾害的损伤机制既有相似之处,又有各自的特点。特点:交流时-主要是枪击和地雷炸伤、出血、有毒物质中毒;灾害时-体温过低或烧伤、机械损伤等。类似的特点包括基础设施、特别是保健设施遭到破坏、药品和医务人员短缺、人道主义危机和其他危机,以及医院里有大量受伤和精神创伤的人。本文对军事冲突期间获得的资料进行了系统整理,并对国内外关于这一主题的文章进行了综述,以期在戒严和资源有限的条件下优化肾病学家的工作。
{"title":"Nephrological care in the conditions of martial law in Ukraine","authors":"L.D. Denova, D. Ivanov, R.R. Andrunevich, O. Korzh, E. Krasyuk","doi":"10.22141/2307-1257.11.3.2022.372","DOIUrl":"https://doi.org/10.22141/2307-1257.11.3.2022.372","url":null,"abstract":"During armed conflicts (AC) and other disasters, the elderly, women, children, the infirm and the chronically ill patients are the most vulnerable population, with a high risk to health and life. Chronically ill people with kidney diseases, including those with kidney failure, deserve special attention due to their complete dependence on available functional infrastructure, and access to vital drugs and well-trained personnel. Currently, there is little information on the effects of AC on patients with kidney damage compared to the available data about the effects of other disasters. Mechanisms of injuries in AC and natural or man-made disasters have similar and distinctive features. Distinctive features: during AC — mainly gunshot and mine blast injuries, bleedings, poisonings by toxic substances, during disasters — hypothermia or burns, mechanical injuries, etc. Similar features include damage to infrastructure, particularly health care facilities, shortage of medicines, medical personnel, humanitarian and other crises, and a large number of injured and traumatized people in the hospitals. In this article, we systematized the material obtained during the military conflict, as well as reviewed domestic and foreign articles on this topic in order to optimize the work of nephrologists in the conditions of martial law and limited resources.","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"85 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76158015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Distance learning in the system of higher education in Kazakhstan (based on main platforms and services) 哈萨克斯坦高等教育体系中的远程学习(基于主要平台和服务)
Pub Date : 2022-09-24 DOI: 10.22141/2307-1257.11.3.2022.376
I.S. Kalymanov
In this article, the author considers distance learning as a new stage in the development of education. The author focuses on the latest achievements in the educational process, as well as the impact of the self-isolation process on the introduction of distance learning. The main advantages and disadvantages of distance learning technology are determined. The basic principles that a teacher needs to master for conducting distance learning of students are considered. The main educational platforms and services are presented, such as Microsoft Teams, Moodle, Zoom, Cisco Webex, Google Classroom. The main features of each platform and service for distance learning are highlighted. The strengths and weaknesses of each of the above platforms and services are considered.
本文认为远程教育是教育发展的一个新阶段。作者着重介绍了教育过程的最新成果,以及自我隔离过程对远程教育引入的影响。确定了远程学习技术的主要优点和缺点。考虑了教师对学生进行远程教育需要掌握的基本原则。介绍了主要的教育平台和服务,如Microsoft Teams、Moodle、Zoom、Cisco Webex、Google Classroom。强调了每个远程学习平台和服务的主要特点。考虑了上述每种平台和服务的优缺点。
{"title":"Distance learning in the system of higher education in Kazakhstan (based on main platforms and services)","authors":"I.S. Kalymanov","doi":"10.22141/2307-1257.11.3.2022.376","DOIUrl":"https://doi.org/10.22141/2307-1257.11.3.2022.376","url":null,"abstract":"In this article, the author considers distance learning as a new stage in the development of education. The author focuses on the latest achievements in the educational process, as well as the impact of the self-isolation process on the introduction of distance learning. The main advantages and disadvantages of distance learning technology are determined. The basic principles that a teacher needs to master for conducting distance learning of students are considered. The main educational platforms and services are presented, such as Microsoft Teams, Moodle, Zoom, Cisco Webex, Google Classroom. The main features of each platform and service for distance learning are highlighted. The strengths and weaknesses of each of the above platforms and services are considered.","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"70 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91505033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Structure and features of the dynamics of primary disability in the adult population of Ukraine as a result of non-oncological urological diseases 非肿瘤性泌尿系统疾病导致乌克兰成年人口原发性残疾动态的结构和特征
Pub Date : 2022-09-24 DOI: 10.22141/2307-1257.11.3.2022.374
N. Saidakova, S. Pasiechnikov, M. Mitchenko, G. Kononova, V.I. Hrodzinskyy, V.G. Bieliakova
Background. The purpose of the work: to study the structure and features of the dynamics of primary disability among the adult population of Ukraine as a result of non-oncological urological diseases. Materials and methods. The reporting form No. 14 of the State Statistics Service of Ukraine, the statistical sources of the Ukrainian State Research Institute of Medical and Social Problems of Disability, documentation of regional centers for medical and social expertise are used. Results. There is a tendency to reduce the number of people recognized as disabled for the first time due to genitourinary diseases. It has been confirmed that prolonging temporary disability contributes to this. The official reporting of the causes of disability by the class of genitourinary diseases is presented only for chronic glomerulonephritis and chronic pyelonephritis; for 5 years, the incidence of the first nosology increased by 13.0 % (to 43.8 % among 1,549 registered), the second — decreased by 37.4 % (to 20.0 % in all regions except Kyiv). At the same time, there was a tendency to reduce the incidence of disability retirement for reasons classified as “others” (36.2 ± 2.0 % vs. 39.0 ± 1.8 % in 2016, and in the Central and Northeastern regions it reached 49.2 ± 2.8 % and 49.6 ± 4.7 %, respectively). Apart from the two above-mentioned pathologies, the structure of disability causes is as follows: the first three places belonged to urolithiasis, polycystic kidney disease, single kidney, the next three — hydronephrosis, congenital malformations and urethral stricture. With age, the incidence of urolithiasis, polycystic kidney disease, hydronephrosis, urethral stricture increases and the incidence of congenital malformations and a single kidney decreases. Over the years, the assignment of the second group of disability decreases (18.1 ± 3.1 % in 2020 vs. 20.4 ± 2.6 % in 2016), with an increase of the third group (67.8 ± 3.8 % vs. 65.3 ± 3.1 %), and stabilization of the first group (14.1 vs. 14.3 %). Conclusions. During the 5-year observation period, 12.9 % more patients avoided disability and 4.7 % less received groups I and II. A decrease by 37.4 % (to 20.0 %) in the share of chronic pyelonephritis as a cause of disability was observed in all regions except Kyiv. Structure of other causes of disability: urolithiasis — 45.0 %, polycystic kidney disease — 22.1 %, single kidney — 18.8 %, hydronephrosis — 15.4 %, congenital defects — 12.1 %, urethral stricture — 4.7 %. Against the background of the general increase in disability assignments with age, group III disability among others was more common (7.7 % — at the age of up to 39 years, 63.1 % — at pre-retirement age, 67.8 % — at retirement age).
背景。这项工作的目的是:研究乌克兰成人非肿瘤性泌尿系统疾病导致的原发性残疾动态的结构和特征。材料和方法。使用了乌克兰国家统计局第14号报告表、乌克兰国家残疾医疗和社会问题研究所的统计资料来源、区域医疗和社会专门知识中心的文件。结果。由于泌尿生殖系统疾病首次被确认为残疾的人数有减少的趋势。已经证实,长期的暂时残疾会造成这种情况。按泌尿生殖系统疾病类别对残疾原因的官方报告仅针对慢性肾小球肾炎和慢性肾盂肾炎;5年来,第一种疾病的发病率增加了13.0%(在1549名登记病例中为43.8%),第二种疾病的发病率下降了37.4%(除基辅以外的所有地区为20.0%)。与此同时,由于“其他”原因导致的残疾退休发生率呈下降趋势(2016年为36.2%±2.0%,2016年为39.0%±1.8%,中部和东北地区分别为49.2%±2.8%和49.6±4.7%)。除上述两种病理外,致残原因结构如下:前三位为尿石症、多囊肾病、单肾,后三位为肾积水、先天畸形和尿道狭窄。随着年龄的增长,尿石症、多囊肾病、肾积水、尿道狭窄的发病率增加,先天性畸形和单肾的发病率减少。多年来,第二组残疾分配率下降(2020年为18.1±3.1%,2016年为20.4±2.6%),第三组增加(67.8±3.8%,2016年为65.3±3.1%),第一组稳定(14.1,2016年为14.3%)。结论。在5年的观察期内,避免残疾的患者增加12.9%,而接受I和II组的患者减少4.7%。在除基辅以外的所有地区,慢性肾盂肾炎作为致残原因的比例下降了37.4%(至20.0%)。其他致残原因的结构:尿石症45.0%,多囊肾病22.1%,单肾18.8%,肾积水15.4%,先天性缺陷12.1%,尿道狭窄4.7%。在残疾分配随年龄增长而普遍增加的背景下,第三类残疾在其他类别中更为常见(7.7% -在39岁以下,63.1% -在退休前年龄,67.8% -在退休年龄)。
{"title":"Structure and features of the dynamics of primary disability in the adult population of Ukraine as a result of non-oncological urological diseases","authors":"N. Saidakova, S. Pasiechnikov, M. Mitchenko, G. Kononova, V.I. Hrodzinskyy, V.G. Bieliakova","doi":"10.22141/2307-1257.11.3.2022.374","DOIUrl":"https://doi.org/10.22141/2307-1257.11.3.2022.374","url":null,"abstract":"Background. The purpose of the work: to study the structure and features of the dynamics of primary disability among the adult population of Ukraine as a result of non-oncological urological diseases. Materials and methods. The reporting form No. 14 of the State Statistics Service of Ukraine, the statistical sources of the Ukrainian State Research Institute of Medical and Social Problems of Disability, documentation of regional centers for medical and social expertise are used. Results. There is a tendency to reduce the number of people recognized as disabled for the first time due to genitourinary diseases. It has been confirmed that prolonging temporary disability contributes to this. The official reporting of the causes of disability by the class of genitourinary diseases is presented only for chronic glomerulonephritis and chronic pyelonephritis; for 5 years, the incidence of the first nosology increased by 13.0 % (to 43.8 % among 1,549 registered), the second — decreased by 37.4 % (to 20.0 % in all regions except Kyiv). At the same time, there was a tendency to reduce the incidence of disability retirement for reasons classified as “others” (36.2 ± 2.0 % vs. 39.0 ± 1.8 % in 2016, and in the Central and Northeastern regions it reached 49.2 ± 2.8 % and 49.6 ± 4.7 %, respectively). Apart from the two above-mentioned pathologies, the structure of disability causes is as follows: the first three places belonged to urolithiasis, polycystic kidney disease, single kidney, the next three — hydronephrosis, congenital malformations and urethral stricture. With age, the incidence of urolithiasis, polycystic kidney disease, hydronephrosis, urethral stricture increases and the incidence of congenital malformations and a single kidney decreases. Over the years, the assignment of the second group of disability decreases (18.1 ± 3.1 % in 2020 vs. 20.4 ± 2.6 % in 2016), with an increase of the third group (67.8 ± 3.8 % vs. 65.3 ± 3.1 %), and stabilization of the first group (14.1 vs. 14.3 %). Conclusions. During the 5-year observation period, 12.9 % more patients avoided disability and 4.7 % less received groups I and II. A decrease by 37.4 % (to 20.0 %) in the share of chronic pyelonephritis as a cause of disability was observed in all regions except Kyiv. Structure of other causes of disability: urolithiasis — 45.0 %, polycystic kidney disease — 22.1 %, single kidney — 18.8 %, hydronephrosis — 15.4 %, congenital defects — 12.1 %, urethral stricture — 4.7 %. Against the background of the general increase in disability assignments with age, group III disability among others was more common (7.7 % — at the age of up to 39 years, 63.1 % — at pre-retirement age, 67.8 % — at retirement age).","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77313166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronobiological aspects of the excretory system (review) 排泄系统的时间生物学方面(综述)
Pub Date : 2022-09-24 DOI: 10.22141/2307-1257.11.3.2022.377
V. Bezruk, D. Ivanov, I. Shkrobanets
The paper examines the issues of circadian rhythms functioning and their significance in the regulation of physiolo­gical processes of the excretory system. The article deals with the issue of desynchronosis, its causes and effects on the physiological processes of the excretory system in children. The practical significance of chronobiological aspects, their dependence on both individual and population factors, the dynamism of such disturbances and their relevance in the age aspect are shown. The value of chronobiological aspects in the functioning of the excretory system and the expediency of continuing scientific and practical research in this direction of medical science were emphasized.
本文探讨了生理节律功能的问题及其在调节排泄系统生理过程中的意义。本文讨论了儿童排泄系统不同步的问题,其原因及其对排泄系统生理过程的影响。显示了时间生物学方面的实际意义,它们对个体和群体因素的依赖,这些干扰的动态及其在年龄方面的相关性。强调了时间生物学方面在排泄系统功能方面的价值,以及在医学科学的这一方向继续进行科学和实践研究的便利性。
{"title":"Chronobiological aspects of the excretory system (review)","authors":"V. Bezruk, D. Ivanov, I. Shkrobanets","doi":"10.22141/2307-1257.11.3.2022.377","DOIUrl":"https://doi.org/10.22141/2307-1257.11.3.2022.377","url":null,"abstract":"The paper examines the issues of circadian rhythms functioning and their significance in the regulation of physiolo­gical processes of the excretory system. The article deals with the issue of desynchronosis, its causes and effects on the physiological processes of the excretory system in children. The practical significance of chronobiological aspects, their dependence on both individual and population factors, the dynamism of such disturbances and their relevance in the age aspect are shown. The value of chronobiological aspects in the functioning of the excretory system and the expediency of continuing scientific and practical research in this direction of medical science were emphasized.","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84779485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect size of Dna-j heat shock protein family B member 9 (DNAJB9) biomarker in kidney biopsy specimens on kidney outcomes in fibrillary glomerulonephritis 肾活检标本中Dna-j热休克蛋白家族B成员9 (DNAJB9)生物标志物对原纤维性肾小球肾炎肾脏预后的效应大小
Pub Date : 2022-09-24 DOI: 10.22141/2307-1257.11.3.2022.373
Fateme Shamekhi Amiri
Background. Fibrillary glomerulonephritis is a rare glomerular disease that presents with hypertension, hematuria, nephrotic syndrome and renal insufficiency. The purpose of this research was to assess effect of DNAjB9 staining marker in kidney biopsy specimens on kidney outcomes. Materials and methods. In this analytic (experimental) clinical study with randomized clinical trial design in meta-analysis article, 72 patients with biopsy-proven fibrillary glomerulonephritis were investigated. Clinical features, laboratory data at initial presentation, management and outcomes were collected. The paper has written based on searching PubMed Central and Google Scholar to identify potentially relevant articles. Median, percentage, mean ± standard deviation (SD), two-tailed t and Chi-square, two proportion difference meta-analysis and Kaplan-Meier analysis were used for statistical evaluation. Moreover, relative risk, odds ratio, Spearman’s correlation for statistical analyses were used. Results. The median and interquartile range of age of patients with fibrillary nephropathy at the time of diagnosis were 55 and 18 years, respectively. There was no statistically significant difference between two sex groups of males and females in current research ­(p-value: 0.35). There was significant statistical correlation between elevated serum creatinine level and time of last serum creatinine measurement with p-value of 0.01 and confidence interval (CI) of 0.7820 to –0.1258 during follow-up. Relative risk of kidney failure progression to kidney replacement therapy (↑ ≥ 2-fold in serum creatinine or dialysis or kidney transplant) in DNAjB9-positive (group I) and DNAjB9-ne­gative patients (group II) was assessed 2.67 with 95% CI of 1.128 to 6.3044 and p-value of 0.025. Odds ratio of kidney failure progression to kidney replacement therapy (↑ ≥ 2-fold in serum creatinine or dialysis or kidney transplant) was assessed 4.33 with 95% CI of 0.9464 to 19.8417 and p-value of 0.058. There was statistically significant difference when comparing group I and group II for mortality probability (Kaplan-Meier analysis) during follow-up (P < 0.0001). Conclusions. The present study revealed high mortality in DNAjB9-negative (8/64, 12.5%) versus DNAjB9-positive patients (0/8) with statistically significant level. Relative risk and odds ratio of kidney failure progression to kidney replacement therapy were assessed 2.67 and 4.33, respectively.
背景。原纤维性肾小球肾炎是一种罕见的肾小球疾病,表现为高血压、血尿、肾病综合征和肾功能不全。本研究的目的是评估肾活检标本中DNAjB9染色标记物对肾脏预后的影响。材料和方法。本荟萃分析文章采用随机临床试验设计,对72例活检证实的原纤维性肾小球肾炎患者进行分析(实验)临床研究。收集临床特征、初次就诊时的实验室数据、处理和结果。这篇论文是基于搜索PubMed Central和Google Scholar来识别潜在的相关文章而写的。采用中位数、百分比、均数±标准差(SD)、双尾t和卡方、双比例差异meta分析和Kaplan-Meier分析进行统计评价。采用相对危险度、优势比、Spearman相关进行统计分析。结果。纤原性肾病患者在诊断时的年龄中位数和四分位数范围分别为55岁和18岁。在目前的研究中,男性和女性两性别组间的差异无统计学意义(p值:0.35)。随访期间血清肌酐水平升高与最后一次测定时间有显著的统计学相关性,p值为0.01,可信区间(CI)为0.7820 ~ -0.1258。dnajb9阳性(I组)和dnajb9阴性(II组)患者肾衰竭进展到肾脏替代治疗的相对风险(↑≥2倍于血清肌酐或透析或肾移植)评估为2.67,95% CI为1.128至6.3044,p值为0.025。评估肾衰竭进展到肾脏替代治疗的优势比(↑≥2倍于血清肌酐、透析或肾移植)为4.33,95% CI为0.9464 ~ 19.8417,p值为0.058。I组与II组随访期间死亡概率(Kaplan-Meier分析)比较,差异有统计学意义(P < 0.0001)。结论。本研究显示,dnajb9阴性患者的死亡率(8/64,12.5%)高于dnajb9阳性患者(0/8),差异有统计学意义。评估肾衰竭进展到肾脏替代治疗的相对风险和优势比分别为2.67和4.33。
{"title":"Effect size of Dna-j heat shock protein family B member 9 (DNAJB9) biomarker in kidney biopsy specimens on kidney outcomes in fibrillary glomerulonephritis","authors":"Fateme Shamekhi Amiri","doi":"10.22141/2307-1257.11.3.2022.373","DOIUrl":"https://doi.org/10.22141/2307-1257.11.3.2022.373","url":null,"abstract":"Background. Fibrillary glomerulonephritis is a rare glomerular disease that presents with hypertension, hematuria, nephrotic syndrome and renal insufficiency. The purpose of this research was to assess effect of DNAjB9 staining marker in kidney biopsy specimens on kidney outcomes. Materials and methods. In this analytic (experimental) clinical study with randomized clinical trial design in meta-analysis article, 72 patients with biopsy-proven fibrillary glomerulonephritis were investigated. Clinical features, laboratory data at initial presentation, management and outcomes were collected. The paper has written based on searching PubMed Central and Google Scholar to identify potentially relevant articles. Median, percentage, mean ± standard deviation (SD), two-tailed t and Chi-square, two proportion difference meta-analysis and Kaplan-Meier analysis were used for statistical evaluation. Moreover, relative risk, odds ratio, Spearman’s correlation for statistical analyses were used. Results. The median and interquartile range of age of patients with fibrillary nephropathy at the time of diagnosis were 55 and 18 years, respectively. There was no statistically significant difference between two sex groups of males and females in current research ­(p-value: 0.35). There was significant statistical correlation between elevated serum creatinine level and time of last serum creatinine measurement with p-value of 0.01 and confidence interval (CI) of 0.7820 to –0.1258 during follow-up. Relative risk of kidney failure progression to kidney replacement therapy (↑ ≥ 2-fold in serum creatinine or dialysis or kidney transplant) in DNAjB9-positive (group I) and DNAjB9-ne­gative patients (group II) was assessed 2.67 with 95% CI of 1.128 to 6.3044 and p-value of 0.025. Odds ratio of kidney failure progression to kidney replacement therapy (↑ ≥ 2-fold in serum creatinine or dialysis or kidney transplant) was assessed 4.33 with 95% CI of 0.9464 to 19.8417 and p-value of 0.058. There was statistically significant difference when comparing group I and group II for mortality probability (Kaplan-Meier analysis) during follow-up (P < 0.0001). Conclusions. The present study revealed high mortality in DNAjB9-negative (8/64, 12.5%) versus DNAjB9-positive patients (0/8) with statistically significant level. Relative risk and odds ratio of kidney failure progression to kidney replacement therapy were assessed 2.67 and 4.33, respectively.","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"114 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78955801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal replacement therapy: does the patient have a choice? 肾脏替代治疗:患者有选择吗?
Pub Date : 2022-09-24 DOI: 10.22141/2307-1257.11.3.2022.375
D. Ivanov
Nowadays there is an emerging problem with renal replacement therapy in the world. Its main methods include dialysis and renal transplantation. However, many regions in the world do not have access to one or more therapy methods due to numerous economic, social, and other factors. Hemodialysis and peritoneal dialysis are shown to be equally efficient, however, it may be difficult to choose one. For each patient who is faced with the choice of a method of renal replacement therapy, the question is which way to choose. The moral and social aspects of such a choice are quite complex. Therefore, the role of a doctor, in addition to the qualified performance of renal replacement therapy, is largely advisory and requires patience and understanding of a patient. It is important to raise the awareness of patients and the level of medical staff education as well as provide equal access to all renal replacement therapy types in the world.
目前,肾脏替代疗法在国际上是一个新兴的问题。其主要方法有透析和肾移植。然而,由于许多经济、社会和其他因素,世界上许多地区无法获得一种或多种治疗方法。血液透析和腹膜透析是同样有效的,然而,可能很难选择一个。对于每个面临肾脏替代治疗方法选择的患者,问题是选择哪一种方法。这种选择的道德和社会方面是相当复杂的。因此,医生的作用,除了进行合格的肾脏替代治疗外,很大程度上是咨询,需要病人的耐心和理解。重要的是要提高患者的认识和医务人员的教育水平,并在世界范围内提供所有肾脏替代疗法类型的平等机会。
{"title":"Renal replacement therapy: does the patient have a choice?","authors":"D. Ivanov","doi":"10.22141/2307-1257.11.3.2022.375","DOIUrl":"https://doi.org/10.22141/2307-1257.11.3.2022.375","url":null,"abstract":"Nowadays there is an emerging problem with renal replacement therapy in the world. Its main methods include dialysis and renal transplantation. However, many regions in the world do not have access to one or more therapy methods due to numerous economic, social, and other factors. Hemodialysis and peritoneal dialysis are shown to be equally efficient, however, it may be difficult to choose one. For each patient who is faced with the choice of a method of renal replacement therapy, the question is which way to choose. The moral and social aspects of such a choice are quite complex. Therefore, the role of a doctor, in addition to the qualified performance of renal replacement therapy, is largely advisory and requires patience and understanding of a patient. It is important to raise the awareness of patients and the level of medical staff education as well as provide equal access to all renal replacement therapy types in the world.","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"391 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91470712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spontaneous retrograde urolithiasis migration in a woman: a case report and possible mechanism 女性自发性逆行性尿石症迁移:1例报告及可能机制
Pub Date : 2022-09-24 DOI: 10.22141/2307-1257.11.3.2022.380
T. Saliba, H. Salame, D. Tack
Urolithiasis is a condition which is commonly encountered in practice, however retrograde migration of a calculus within the ureter has only recently been documented with few cases reported in the literature. We present the case of a 47-year-old woman presenting with symptomatic urolithiasis confirmed by CT who recovered from her symptoms only for it to be discovered that the calculus had undergone retrograde migration into the renal calyx on a follow up CT examination. We theorise that retrograde urolithiasis migration may be an innate safety mechanism that evolved to prevent complications and/or death from urolithiasis impaction by attempting to return a migrated lithiasis to the renal calyx.
尿石症是在实践中常见的一种情况,然而输尿管内结石的逆行迁移直到最近才被记录在案,文献报道的病例很少。我们报告一名47岁的女性,经CT证实有症状性尿石症,她从症状中恢复,但在随访的CT检查中发现结石逆行迁移到肾盂。我们推测,逆行性尿石迁移可能是一种先天安全机制,通过试图将迁移的结石返回肾盂,从而防止尿石阻塞引起的并发症和/或死亡。
{"title":"Spontaneous retrograde urolithiasis migration in a woman: a case report and possible mechanism","authors":"T. Saliba, H. Salame, D. Tack","doi":"10.22141/2307-1257.11.3.2022.380","DOIUrl":"https://doi.org/10.22141/2307-1257.11.3.2022.380","url":null,"abstract":"Urolithiasis is a condition which is commonly encountered in practice, however retrograde migration of a calculus within the ureter has only recently been documented with few cases reported in the literature. We present the case of a 47-year-old woman presenting with symptomatic urolithiasis confirmed by CT who recovered from her symptoms only for it to be discovered that the calculus had undergone retrograde migration into the renal calyx on a follow up CT examination. We theorise that retrograde urolithiasis migration may be an innate safety mechanism that evolved to prevent complications and/or death from urolithiasis impaction by attempting to return a migrated lithiasis to the renal calyx.","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89022235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regulatory mechanisms for maintaining homeostasis of sodium ions 钠离子维持体内平衡的调控机制
Pub Date : 2022-09-24 DOI: 10.22141/2307-1257.11.3.2022.378
N. Filipets, A. Gozhenko, D. Ivanov, O. Filipets, L. Gabunia
According to general scientific recognition, the content of sodium ions in the body of a healthy person is quite constant, and among the multifaceted biological functions of this electrolyte, participation in maintaining water-salt homeostasis is the most important. Deviations from the normal level of concentration of sodium ions in the blood plasma are the most common electrolyte balance disorders in clinical medicine; however, dysionias still remain a relevant subject of research, in particular, their pathogenetic aspects and the possibilities of pharmacological correction. Sodium as an electrolyte is essential for the vo­lume of extracellular fluid the content of which is inversely related to the urinary excretion of sodium ions. Sodium homeostasis is tightly regulated. In the reactions of ensuring the sodium balance in the body, the kidneys play a leading role, and the changes in their functional state are mediated through the action of the basic neurohumoral regulatory systems. The main renal homeostatic processes — glomerular filtration, tubular reabsorption and secretion — are of decisive importance for the removal of excess ions of sodium or its retention in the body. At the same time, it was found that there are also extrarenal mechanisms that are still being studied. Moreover, a number of studies have suggested that sodium ions can be stored in body tissues without adequate retention of water to buffer the electrolyte. Given the participation of the kidneys in maintaining normal functional and metabolic relationships and in pathological syndromes related to other organs, it is possible to predict the correlation of the activity of established and new markers of extrarenal mechanisms with reducers of water-electrolyte exchange the final effects of which are mediated through changes in the functional state of the kidneys. Evaluation of additional sodium-regulatory systems is a promising current direction for expanding ideas about mechanisms of stability of electrolytes and water.
根据普遍的科学认识,健康人体内钠离子的含量是相当恒定的,在这种电解质多方面的生物功能中,参与维持水盐稳态是最重要的。血浆钠离子浓度偏离正常水平是临床医学中最常见的电解质平衡紊乱;然而,精神障碍仍然是一个相关的研究课题,特别是其发病方面和药理学纠正的可能性。钠作为一种电解质对于细胞外液的体积是必不可少的,其含量与尿中钠离子的排泄成反比。钠的体内平衡受到严格的调节。在保证体内钠平衡的反应中,肾脏起主导作用,其功能状态的变化是通过基本的神经-体液调节系统的作用来介导的。主要的肾脏稳态过程——肾小球滤过、肾小管重吸收和分泌——对去除多余的钠离子或其在体内的滞留具有决定性的重要性。与此同时,研究发现,还有一些外部机制仍在研究中。此外,许多研究表明,钠离子可以储存在身体组织中,没有足够的水潴留来缓冲电解质。鉴于肾脏参与维持正常的功能和代谢关系以及与其他器官相关的病理综合征,有可能预测已建立的和新的肾外机制标记物的活性与水电解质交换减少物的相关性,其最终效果是通过肾脏功能状态的变化介导的。评价额外的钠调节系统是一个有前途的当前方向,以扩大思路的稳定性机制的电解质和水。
{"title":"Regulatory mechanisms for maintaining homeostasis of sodium ions","authors":"N. Filipets, A. Gozhenko, D. Ivanov, O. Filipets, L. Gabunia","doi":"10.22141/2307-1257.11.3.2022.378","DOIUrl":"https://doi.org/10.22141/2307-1257.11.3.2022.378","url":null,"abstract":"According to general scientific recognition, the content of sodium ions in the body of a healthy person is quite constant, and among the multifaceted biological functions of this electrolyte, participation in maintaining water-salt homeostasis is the most important. Deviations from the normal level of concentration of sodium ions in the blood plasma are the most common electrolyte balance disorders in clinical medicine; however, dysionias still remain a relevant subject of research, in particular, their pathogenetic aspects and the possibilities of pharmacological correction. Sodium as an electrolyte is essential for the vo­lume of extracellular fluid the content of which is inversely related to the urinary excretion of sodium ions. Sodium homeostasis is tightly regulated. In the reactions of ensuring the sodium balance in the body, the kidneys play a leading role, and the changes in their functional state are mediated through the action of the basic neurohumoral regulatory systems. The main renal homeostatic processes — glomerular filtration, tubular reabsorption and secretion — are of decisive importance for the removal of excess ions of sodium or its retention in the body. At the same time, it was found that there are also extrarenal mechanisms that are still being studied. Moreover, a number of studies have suggested that sodium ions can be stored in body tissues without adequate retention of water to buffer the electrolyte. Given the participation of the kidneys in maintaining normal functional and metabolic relationships and in pathological syndromes related to other organs, it is possible to predict the correlation of the activity of established and new markers of extrarenal mechanisms with reducers of water-electrolyte exchange the final effects of which are mediated through changes in the functional state of the kidneys. Evaluation of additional sodium-regulatory systems is a promising current direction for expanding ideas about mechanisms of stability of electrolytes and water.","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90244437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rituximab use in the treatment of children with nephrotic syndrome 利妥昔单抗在儿童肾病综合征治疗中的应用
Pub Date : 2022-07-13 DOI: 10.22141/2307-1257.11.2.2022.365
L. Vakulenko, O. Lytvynova, I.V. Posmitjuha
Background. High recurrence rates of nephrotic syndrome in children and consequences in the form of steroid dependence and a high risk of side effects from corticosteroids as a result involve immunosuppressive steroid-preserving agents that would increase long-term remission. Rituximab, a chimeric anti-CD20 monoclonal antibody that inhibits CD20-mediated B-cell proliferation and differentiation, has been identified as a possible alternative treatment. The purpose of the study — to estimate the efficacy and safety of treatment recurrence of nephrotic syndrome in children using rituximab like we did it on three clinical cases. Materials and methods. The experience of rituximab in children was analyzed according to the databases of Scopus, Web of Science, MedLine, The Cochrane Library, EMBASE, Global Health and our own study of the treatment of three children with steroid-sensitive nephrotic syndrome was presented. Results. Treatment of nephrotic syndrome in three children who are 5 to 7 years with rituximab was conducted. One child had a second recurrence, two children had a first recurrence. The previous episode of nephrotic syndrome in all children was treated according to the recommendations of KDIGO 2021. All patients received rituximab (two intravenous injections two weeks apart) at a dose of 15 mg/kg for 5–6 hours with prior administration of methylprednisolone at a dose of 7–10 mg/kg. One child had side effects to the first administration of rituximab in the form of hypotension 70/40 and tachycardia 116–118. Reducing the speed of administration helped to eliminate side effects. The next injection in two weeks the child endured well. The other two children had no side effects to both rituximab injections. Moreover after 1 month of rituximab administration was without side effects or hematological changes. The next administration of ritu­ximab is scheduled in 6 months after the last administration with prior control of CD20 level. Conclusions. In general a review of studies of rituximab confirms the high efficacy of the medication in nephrotic syndrome in children and the requirement for long-term evaluation. Rituximab can be considered as a first-line treatment for recurrence of nephrotic syndrome, including in resource-limited settings. Our own experience with rituximab in recurrent nephrotic syndrome has revealed slight short-term side effects.
背景。儿童肾病综合征的高复发率和以类固醇依赖的形式产生的后果以及皮质类固醇的高风险副作用涉及免疫抑制类固醇保存剂,这将增加长期缓解。Rituximab是一种嵌合抗cd20单克隆抗体,可抑制cd20介导的b细胞增殖和分化,已被确定为一种可能的替代治疗方法。这项研究的目的是评估使用利妥昔单抗治疗儿童肾病综合征复发的有效性和安全性,就像我们对三个临床病例所做的那样。材料和方法。根据Scopus、Web of Science、MedLine、The Cochrane Library、EMBASE、Global Health等数据库对利妥昔单抗在儿童中的应用经验进行分析,并介绍我们自己对3例类固醇敏感性肾病综合征患儿的治疗研究。结果。采用利妥昔单抗治疗3例5 ~ 7岁儿童肾病综合征。一个孩子有第二次复发,两个孩子有第一次复发。所有儿童既往肾病综合征发作均根据KDIGO 2021的建议进行治疗。所有患者均接受利妥昔单抗治疗(两次静脉注射,间隔两周),剂量为15mg /kg,持续5-6小时,之前给予甲基强的松龙,剂量为7 - 10mg /kg。1例患儿首次使用利妥昔单抗后出现低血压70/40和心动过速116-118的副作用。降低给药速度有助于消除副作用。两周后,孩子接受了第二次注射。另外两名儿童对两种利妥昔单抗注射均无副作用。此外,利妥昔单抗给药1个月后,无副作用或血液学改变。下次给药ritu-ximab计划在最后一次给药后6个月,事先控制CD20水平。结论。总的来说,对利妥昔单抗研究的回顾证实了该药对儿童肾病综合征的高疗效和长期评估的必要性。利妥昔单抗可以被认为是肾病综合征复发的一线治疗,包括在资源有限的情况下。我们自己使用利妥昔单抗治疗复发性肾病综合征的经验显示有轻微的短期副作用。
{"title":"Rituximab use in the treatment of children with nephrotic syndrome","authors":"L. Vakulenko, O. Lytvynova, I.V. Posmitjuha","doi":"10.22141/2307-1257.11.2.2022.365","DOIUrl":"https://doi.org/10.22141/2307-1257.11.2.2022.365","url":null,"abstract":"Background. High recurrence rates of nephrotic syndrome in children and consequences in the form of steroid dependence and a high risk of side effects from corticosteroids as a result involve immunosuppressive steroid-preserving agents that would increase long-term remission. Rituximab, a chimeric anti-CD20 monoclonal antibody that inhibits CD20-mediated B-cell proliferation and differentiation, has been identified as a possible alternative treatment. The purpose of the study — to estimate the efficacy and safety of treatment recurrence of nephrotic syndrome in children using rituximab like we did it on three clinical cases. Materials and methods. The experience of rituximab in children was analyzed according to the databases of Scopus, Web of Science, MedLine, The Cochrane Library, EMBASE, Global Health and our own study of the treatment of three children with steroid-sensitive nephrotic syndrome was presented. Results. Treatment of nephrotic syndrome in three children who are 5 to 7 years with rituximab was conducted. One child had a second recurrence, two children had a first recurrence. The previous episode of nephrotic syndrome in all children was treated according to the recommendations of KDIGO 2021. All patients received rituximab (two intravenous injections two weeks apart) at a dose of 15 mg/kg for 5–6 hours with prior administration of methylprednisolone at a dose of 7–10 mg/kg. One child had side effects to the first administration of rituximab in the form of hypotension 70/40 and tachycardia 116–118. Reducing the speed of administration helped to eliminate side effects. The next injection in two weeks the child endured well. The other two children had no side effects to both rituximab injections. Moreover after 1 month of rituximab administration was without side effects or hematological changes. The next administration of ritu­ximab is scheduled in 6 months after the last administration with prior control of CD20 level. Conclusions. In general a review of studies of rituximab confirms the high efficacy of the medication in nephrotic syndrome in children and the requirement for long-term evaluation. Rituximab can be considered as a first-line treatment for recurrence of nephrotic syndrome, including in resource-limited settings. Our own experience with rituximab in recurrent nephrotic syndrome has revealed slight short-term side effects.","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"191 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77490746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Standardization of provision of medical care for children: joint agreed local clinical protocol of medical care for children with urinary tract infections at the level of the hospital district 为儿童提供医疗服务的标准化:医院区一级尿路感染儿童医疗服务的联合商定地方临床协议
Pub Date : 2022-07-13 DOI: 10.22141/2307-1257.11.2.2022.366
V. Bezruk, D. Ivanov, S. Fomina, T. Andriychuk, O. I. Pervozvanska, T. R. Andriychuk
In the modern development of medicine, the issue of providing medical care on the basis of evidence-based and personalized medicine becomes especially relevant. The system of standardization of medical care is focused on the development and implementation of medical and technological documents that help the doctor to act effectively in specific clinical situations, avoiding ineffective actions and interventions. The article highlights the approaches to improving the quality of medical care for children at the regional level - a joint agreed local clinical protocol for medical care for children with urinary tract infections (coordination of the patient's clinical route and standardization of diagnostic, therapeutic and preventive measures in health care facilities at the level of the hospital).
在现代医学发展中,以循证医学和个性化医学为基础提供医疗服务的问题变得尤为重要。医疗保健标准化体系的重点是制定和实施医疗和技术文件,帮助医生在特定的临床情况下有效地采取行动,避免无效的行动和干预。这篇文章强调了在区域一级提高儿童医疗质量的方法——一项关于尿路感染儿童医疗保健的联合商定的地方临床协议(协调病人的临床路线,并在医院一级的卫生保健设施中标准化诊断、治疗和预防措施)。
{"title":"Standardization of provision of medical care for children: joint agreed local clinical protocol of medical care for children with urinary tract infections at the level of the hospital district","authors":"V. Bezruk, D. Ivanov, S. Fomina, T. Andriychuk, O. I. Pervozvanska, T. R. Andriychuk","doi":"10.22141/2307-1257.11.2.2022.366","DOIUrl":"https://doi.org/10.22141/2307-1257.11.2.2022.366","url":null,"abstract":"In the modern development of medicine, the issue of providing medical care on the basis of evidence-based and personalized medicine becomes especially relevant. The system of standardization of medical care is focused on the development and implementation of medical and technological documents that help the doctor to act effectively in specific clinical situations, avoiding ineffective actions and interventions. The article highlights the approaches to improving the quality of medical care for children at the regional level - a joint agreed local clinical protocol for medical care for children with urinary tract infections (coordination of the patient's clinical route and standardization of diagnostic, therapeutic and preventive measures in health care facilities at the level of the hospital).","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81056039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
KIDNEYS
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1